Indian pediatrics · 2018
Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sood Vikrant, Khanna Rajeev, Rawat Dinesh, Sharma Shvetank, Alam Seema, Sarin Shiv Kumar
Аннотация
OBJECTIVE: To find association of pediatric NAFLD with metabolic risk factors, and Patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene polymorphism.
DESIGN: Cross-sectional study.
SETTING: Pediatric Hepatology unit of a tertiary care hospital.
PARTICIPANTS: Overweight/obese children (<18 years) with (69 patients) or without (30 patients) NAFLD (ultrasonography based), and their parents.
INTERVENTION: Metabolic screening, PNPLA3 gene polymorphism, and transient elastography.
OUTCOME MEASURE: Association of pediatric NAFLD with parental metabolic risk factors and PNPLA3 gene polymorphism.
RESULTS: In the NAFLD group, there was high parental incidence of metabolic diseases, fatty liver (80%) and low high-density lipoproteins levels (84%). Family history of NAFLD (in any parent), higher alanine aminotransferase levels and higher total cholesterol levels in the child independently predicted possibility of NAFLD, but similar results could not be replicated for PNPLA3 gene polymorphism. Controlled attenuation parameter measurement (by transient elastography) had high sensitivity and specificity to diagnose steatosis.
CONCLUSIONS: There is high familial incidence of metabolic diseases in children with NAFLD. Controlled attenuation parameter can be useful as a non-invasive modality to screen fatty liver in children.
DESIGN: Cross-sectional study.
SETTING: Pediatric Hepatology unit of a tertiary care hospital.
PARTICIPANTS: Overweight/obese children (<18 years) with (69 patients) or without (30 patients) NAFLD (ultrasonography based), and their parents.
INTERVENTION: Metabolic screening, PNPLA3 gene polymorphism, and transient elastography.
OUTCOME MEASURE: Association of pediatric NAFLD with parental metabolic risk factors and PNPLA3 gene polymorphism.
RESULTS: In the NAFLD group, there was high parental incidence of metabolic diseases, fatty liver (80%) and low high-density lipoproteins levels (84%). Family history of NAFLD (in any parent), higher alanine aminotransferase levels and higher total cholesterol levels in the child independently predicted possibility of NAFLD, but similar results could not be replicated for PNPLA3 gene polymorphism. Controlled attenuation parameter measurement (by transient elastography) had high sensitivity and specificity to diagnose steatosis.
CONCLUSIONS: There is high familial incidence of metabolic diseases in children with NAFLD. Controlled attenuation parameter can be useful as a non-invasive modality to screen fatty liver in children.
Предметные рубрики MeSH
AdolescentChildCross-Sectional StudiesFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansLipaseMaleMedical History TakingMembrane ProteinsMetabolic DiseasesMultivariate AnalysisNon-alcoholic Fatty Liver DiseaseParentsPolymorphism, Single NucleotideProspective StudiesRisk FactorsAcyltransferasesPhospholipases A2, Calcium-Independent